Research ArticleHuman Studies
Reproducibility and Discriminating Ability of Fluorine-18-6-Fluoro-L-Dopa PET in Parkinson's Disease
François J.G. Vingerhoets, Michael Schulzer, Thomas J. Ruth, James E. Holden and Barry J. Snow
Journal of Nuclear Medicine March 1996, 37 (3) 421-426;
François J.G. Vingerhoets
Michael Schulzer
Thomas J. Ruth
James E. Holden


This is a PDF-only article. The first page of the PDF of this article appears above.
In this issue
Reproducibility and Discriminating Ability of Fluorine-18-6-Fluoro-L-Dopa PET in Parkinson's Disease
François J.G. Vingerhoets, Michael Schulzer, Thomas J. Ruth, James E. Holden, Barry J. Snow
Journal of Nuclear Medicine Mar 1996, 37 (3) 421-426;
Jump to section
Related Articles
- No related articles found.
Cited By...
- Simple Ratio Analysis of 18F-Fluorodopa Uptake in Striatal Subregions Separates Patients with Early Parkinson Disease from Healthy Controls
- Improving Influx Constant and Ratio Estimation in FDOPA Brain PET Analysis for Parkinson's Disease
- Reproducibility of 99mTc-TRODAT-1 SPECT Measurement of Dopamine Transporters in Parkinson's Disease
- Comparative Analysis of Striatal FDOPA Uptake in Parkinson's Disease: Ratio Method Versus Graphical Approach
- Parkinson's disease in twins
- PET studies of parkinsonism associated with mutation in the {alpha}-synuclein gene
- Statistical parametric mapping with 18F-dopa PET shows bilaterally reduced striatal and nigral dopaminergic function in early Parkinson's disease
- Measuring the rate of progression and estimating the preclinical period of Parkinson's disease with [18F]dopa PET